Intravenous beta blockers, diltiazem, procainamide, or verapamil is reasonable for acute treatment in patients with symptomatic<unk>  tachycardia. Oral beta blockers, diltiazem or verapamil is reasonable for ongoing management in patients with<unk>  tachycardia. Flecainide or propafenone may be reasonable for ongoing management in patients without structural heart disease or ischemic heart disease who have<unk>  tachycardia. Catheter ablation may be reasonable in patients with<unk>  tachycardia when medical therapy is not effective or contraindicated.
Supraventricular tachycardia AHA recommendations for Management of Junctional Tachycardia
Supraventricular tachycardia AHA recommendations for Management of Atrial Flutter
Supraventricular tachycardia AHA recommendations for Management of AVNRT
Supraventricular tachycardia AHA recommendations for Management of Orthodromic AVRT
Supraventricular tachycardia AHA recommendations for Management of Multifocal Atria Tachycardia
Supraventricular tachycardia AHA recommendations for Management of IST
Supraventricular tachycardia AHA recommendations for Management of SVT in ACHD Patients
Supraventricular tachycardia AHA recommendations for Management of Suspected Focal Atrial Tachycardia